Grandview Asset Management LLC Amgen Inc Transaction History

Grandview Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$233.58 - $259.14 $52,088 - $57,788	-223 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$221.91 - $258.6 $61,469 - $71,632	-277 Reduced 55.4%	223 $56,000
Q1 2021 May 06, 2021	BUY	$221.91 - $258.6 $110,955 - $129,300	500 New	500 $24,000
Q1 2020 Apr 09, 2020	SELL	$182.24 - $241.7 $172,763 - $229,131	-948 Closed	0 $0
Q4 2019 Jan 28, 2020	SELL	$189.21 - $243.2 $68,304 - $87,795	-361 Reduced 27.58%	948 $228,000
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $19,848 - $23,782	114 Added 9.54%	1,309 $253,000
Q2 2019 Jul 18, 2019	BUY	$166.7 - $195.41 $20,837 - $24,426	125 Added 11.68%	1,195 $220,000
Q1 2019 May 07, 2019	SELL	$180.87 - $203.88 $542 - $611	-3 Reduced 0.28%	1,070 $203,000
Q4 2018 Feb 05, 2019	BUY	$178.4 - $208.25 $191,423 - $223,452	1,073 New	1,073 $209,000

3,090

417M

7.19M

6.13M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Grandview Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Grandview Asset Management LLC with notifications on news.